Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Iron deficiency and overload.

Ernest Beutler1, A Victor Hoffbrand, James D Cook

  • 1The Scripps Research Institute, La Jolla CA 92037, USA.

Hematology. American Society of Hematology. Education Program
|November 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mandatory UK folic acid fortification.

Lancet (London, England)·2021
Same author

The Role of Deferiprone in Iron Chelation. Reply.

The New England journal of medicine·2019
Same author

The Role of Deferiprone in Iron Chelation.

The New England journal of medicine·2018
Same author

In Memoriam Professor Shiro Miwa.

International journal of hematology·2018
Same author

Professor John Scott, folate and neural tube defects.

British journal of haematology·2013
Same author

A complete diet-based algorithm for predicting nonheme iron absorption in adults.

The Journal of nutrition·2013

Recent discoveries reveal numerous genes influencing iron homeostasis, impacting iron storage diseases. Understanding these genetic factors is crucial for diagnosing and managing conditions like hemochromatosis and iron deficiency.

Area of Science:

  • Genetics and Molecular Biology
  • Hematology
  • Clinical Medicine

Background:

  • Numerous genes affecting iron homeostasis have been identified in recent years.
  • These include genes for HFE, DMT-1, ferroportin, transferrin receptor 2, hephaestin, and hepcidin.
  • Understanding these genes is key to differentiating various iron storage diseases.

Purpose of the Study:

  • To provide an overview of newly discovered genes influencing iron homeostasis.
  • To discuss clinical forms of iron storage diseases and their genetic basis.
  • To explore recent findings on the penetrance of hereditary hemochromatosis and management strategies.

Main Methods:

  • Review of genetic discoveries related to iron homeostasis.
  • Discussion of clinical presentations of hereditary and acquired hemochromatosis.

Related Experiment Videos

  • Overview of chelation therapy for secondary hemochromatosis.
  • Comparison of diagnostic methods for iron deficiency.

    • Main Results:

    • Hereditary hemochromatosis is often linked to HFE gene mutations, with lower-than-expected clinical penetrance (around 1%).
    • Juvenile iron storage disease stems from hepcidin gene mutations or other genetic factors.
    • Chelation therapies like desferrioxamine and deferiprone are used for secondary hemochromatosis, with newer agents emerging.
    • Newer diagnostic methods for iron deficiency, such as reticulocyte hemoglobin content, show promise.

    Conclusions:

    • Genetic discoveries have significantly advanced the understanding of iron storage diseases.
    • Clinical penetrance of HFE-related hemochromatosis is lower than previously assumed, impacting management strategies.
    • Effective chelation therapies and diagnostic tools are available for managing iron overload and deficiency.